Effect of Nuclear Factor-Κb Inhibitor on Cancer Cachexia

Jieshou Li

2007-01-01

Abstract:Objective: To investigate the effect of pyrrolidine dithiocarbamate(PDTC) on IL-6 synthesis and cachexia in colon 26 tumor bearing mice.Methods: Male BALB/c mice bearing colon 26 adenocarcinoma were severed as a model of cancer cachexia.Saline and three doses of PDTC(10,50 or 100 mg/kg) were given intraperitoneally daily from 7 days after tumor inoculation to sacrifice.Body weight,food intake and tumor volume were monitored daily.Serum and tumor tissue levels of IL-6,serum biochemical indicator,and activity of NF-κB in tumor tissue were investigated in all animals. Results: Significant tissue wasting was observed in all tumor-bearing mice.By day 16,carcass weights of untreated tumor-bearing mice were about 71.3% of healthy controls(P0.01),and the weights of gastrocnemius muscle and epididymal fat were lowered by 42.4% and 70.4%(P0.01),respectively.Furthermore,tumor-bearing state caused a significant decrease of serum albumin,glucose and triglyceride(P0.01),and increase of IL-6(P0.01) in serum and tumor tissues.Administration of PDTC dose dependently inhibited the NF-κB activation in tumor tissues,inhibited IL-6 synthesis of the tumor cells,and attenuated the wasting of carcass weight,gastrocnemius muscle and epididymal fat.Tumor growth was inhibited by PDTC with 100 mg/kg(P0.05).No differences of food intake were found between groups(P0.05).Conclusion: PDTC can attenuate the development of cachexia in colon 26 tumor bearing mice through inhibition of IL-6 synthesis regulated by NF-κB.